» Articles » PMID: 36656301

A Knockout-first Model of H3f3a Gene Targeting Leads to Developmental Lethality

Overview
Journal Genesis
Date 2023 Jan 19
PMID 36656301
Authors
Affiliations
Soon will be listed here.
Abstract

Histone variant H3.3 is encoded by two genes, H3f3a and H3f3b, which can be expressed differentially depending on tissue type. Previous work in our lab has shown that knockout of H3f3b causes some neonatal lethality and infertility in mice, and chromosomal defects in mouse embryonic fibroblasts (MEFs). Studies of H3f3a and H3f3b null mice by others have produced generally similar phenotypes to what we found in our H3f3b nulls, but the relative impacts of the loss of either H3f3a or H3f3b have varied depending on the approach and genetic background. Here we used a knockout-first approach to target the H3f3a gene for inactivation in C57BL6 mice. Homozygous H3f3a targeting produced a lethal phenotype at or before birth. E13.5 null embryos had some potential morphological differences from WT littermates including smaller size and reduced head size. An E18.5 null embryo was smaller than its control littermates with several potential defects including small head and brain size as well as small lungs, which would be consistent with a late gestation lethal phenotype. Despite a reduction in H3.3 and total H3 protein levels, the only histone H3 post-translational modification in the small panel assessed that was significantly altered was the unique H3.3 mark phospho-Serine31, which was consistently increased in null neurospheres. H3f3a null neurospheres also exhibited consistent gene expression changes including in protocadherins. Overall, our findings are consistent with the model that there are differential, cell-type-specific contributions of H3f3a and H3f3b to H3.3 functions in epigenetic and developmental processes.

Citing Articles

(B)On(e)-cohistones and the epigenetic alterations at the root of bone cancer.

Salomoni P, Flanagan A, Cottone L Cell Death Differ. 2023; 32(1):66-77.

PMID: 37828086 PMC: 11748643. DOI: 10.1038/s41418-023-01227-9.


Knockout tales: the versatile roles of histone H3.3 in development and disease.

Klein R, Knoepfler P Epigenetics Chromatin. 2023; 16(1):38.

PMID: 37814296 PMC: 10563256. DOI: 10.1186/s13072-023-00512-8.


Histone Variants and Their Chaperones in Hematological Malignancies.

Kirkiz E, Meers O, Grebien F, Buschbeck M Hemasphere. 2023; 7(8):e927.

PMID: 37449197 PMC: 10337764. DOI: 10.1097/HS9.0000000000000927.


Involvement of the H3.3 Histone Variant in the Epigenetic Regulation of Gene Expression in the Nervous System, in Both Physiological and Pathological Conditions.

Di Liegro C, Schiera G, Schiro G, Di Liegro I Int J Mol Sci. 2023; 24(13).

PMID: 37446205 PMC: 10342106. DOI: 10.3390/ijms241311028.

References
1.
Jang C, Shibata Y, Starmer J, Yee D, Magnuson T . Histone H3.3 maintains genome integrity during mammalian development. Genes Dev. 2015; 29(13):1377-92. PMC: 4511213. DOI: 10.1101/gad.264150.115. View

2.
Banaszynski L, Wen D, Dewell S, Whitcomb S, Lin M, Diaz N . Hira-dependent histone H3.3 deposition facilitates PRC2 recruitment at developmental loci in ES cells. Cell. 2013; 155(1):107-20. PMC: 3838450. DOI: 10.1016/j.cell.2013.08.061. View

3.
Yuen B, Bush K, Barrilleaux B, Cotterman R, Knoepfler P . Histone H3.3 regulates dynamic chromatin states during spermatogenesis. Development. 2014; 141(18):3483-94. PMC: 4197731. DOI: 10.1242/dev.106450. View

4.
Bachu M, Tamura T, Chen C, Narain A, Nehru V, Sarai N . A versatile mouse model of epitope-tagged histone H3.3 to study epigenome dynamics. J Biol Chem. 2018; 294(6):1904-1914. PMC: 6369307. DOI: 10.1074/jbc.RA118.005550. View

5.
Couldrey C, Carlton M, Nolan P, Colledge W, Evans M . A retroviral gene trap insertion into the histone 3.3A gene causes partial neonatal lethality, stunted growth, neuromuscular deficits and male sub-fertility in transgenic mice. Hum Mol Genet. 1999; 8(13):2489-95. DOI: 10.1093/hmg/8.13.2489. View